Results 181 to 190 of about 48,974 (212)

Immunotherapeutic approaches in HNSCC

2020
Nicole C. Schmitt, Robert L. Ferris
openaire   +1 more source

The current advances and future directions of PD-1/PD-L1 blockade in head and neck squamous cell carcinoma (HNSCC) in the era of immunotherapy

International Immunopharmacology, 2023
Xianbin Zhang, Xingchen Ding, Man Hu
exaly  

[Immunotherapy for HNSCC : Quo vadis?].

HNO, 2017
Immunotherapy remains a hot topic with an endless stream of new upcoming clinical trials. The results of studies to date are promising for second-line palliative treatment of head and neck squamous cell carcinoma (HNSCC). The next step is testing these strategies in randomized trials for first-line and curative treatment in an adjuvant, neoadjuvant ...
J, Döscher, C-J, Busch, P J, Schuler, S, Laban   +3 more
openaire   +1 more source

Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity

Frontiers in Immunology, 2023
Gang Tian, Jinhui Liu, Hao Chi
exaly  

FKBP1A upregulation correlates with poor prognosis and increased metastatic potential of HNSCC

Cell Biology International, 2022
Mayurbhai H Sahani, Pavan Agrawal, Deepak Kanojia   +2 more
exaly  

Pathology of HNSCC

2018
Michelle D. Williams, Adel K. El-Naggar
openaire   +1 more source

Top bar navigation

Frontiers in Genetics, 2022
Qinglai Tang, Shisheng Li, Xinming Yang
exaly  

Erk1/2-Dependent HNSCC Cell Susceptibility to Erastin-Induced Ferroptosis

Cells, 2023
Herbert Riechelmann, Dragana Savic, Ira-Ida Skvortsova   +2 more
exaly  

Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis

Journal of Pineal Research, 2021
Xinyuan Zhao, Shen Hu, Li Cui
exaly  

CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines

Biomedicines, 2021
Janeen Trembley, Khalil Ahmed, Betsy T Kren   +2 more
exaly